Bellicum's cancer drug trials on clinical hold, shares tumble

(Reuters) - Bellicum Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of the company's experimental cancer drug after three cases of brain disease linked to head trauma.